{
    "title": "U.S. FDA panel votes successful study on Biogen Alzheimer's drug cannot stand alone",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8922755/U-S-FDA-panel-votes-successful-study-Biogen-Alzheimers-drug-stand-alone.html",
    "date": "2020-11-06",
    "keywords": [
        "panel",
        "drug",
        "biogen",
        "trial",
        "approval",
        "disease",
        "evidence",
        "study",
        "manojna",
        "maddipatla",
        "fda",
        "treatment",
        "progression",
        "meeting",
        "analysis",
        "effectiveness",
        "beasley",
        "food",
        "administration",
        "incs",
        "regard",
        "consideration",
        "proof",
        "efficacy",
        "decision",
        "march",
        "aducanumab",
        "mindwasting",
        "condition",
        "cause",
        "death",
        "profound",
        "unmet",
        "need",
        "director",
        "neurology",
        "center",
        "evaluation",
        "research",
        "october",
        "year",
        "futility",
        "course",
        "dose",
        "staff",
        "week",
        "effect",
        "failure",
        "friday",
        "earlystage",
        "reporting",
        "bengaluru",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}